Jonathan Tran

Jonathan Tran has a extensive work experience in the field of clinical pharmacology and non-clinical development. Jonathan currently holds the position of Vice President, Clinical Pharmacology & Non-Clinical Development at Mirati Therapeutics since June 2020. Prior to this role, they served as the Executive Director of Clinical Pharmacology & Early Clinical Development at Bristol-Myers Squibb from November 2019 to May 2020. Before that, they were the Executive Director of Clinical Pharmacology at Celgene from July 2015 to November 2019. Jonathan also held the positions of Head of Clinical Pharmacology & Early Development Leader at Biogen from May 2011 to July 2015, Sr. Director of Clinical Pharmacology at Roche from January 2008 to April 2011, and Director of Clinical Pharmacology & Early Development Leader at Amgen from 2005 to 2008. Jonathan began their career as an Associate Director - Clinical Pharmacology at Pfizer from 1999 to 2005 and as a Clinical Pharmacology & Drug Development Fellow at SmithKline Beecham from June 1997 to May 1999.

Jonathan Tran earned a Bachelor of Science degree in Biochemistry from San Francisco State University in 1992. Jonathan later attended the University of California, San Francisco, where they graduated with a Doctor of Pharmacy degree in Clinical Pharmacy in 1997.